stannous protoporphyrin
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2019 (NCT04072861)
Timeline
Indications
Mechanism of action
- Heme oxygenase 1INHIBITOR
HMOX1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04564833 | Phase 2 | Nov 23, 2020 | Renibus Therapeutics, Inc. |
| NCT04371822 | Phase 1 | May 31, 2020 | Damitta University, Kafrelsheikh University |
| NCT03893799 | Phase 1 | Aug 15, 2019 | Renibus Therapeutics, Inc. |
| NCT04072861 | Phase 1 | Mar 31, 2019 | Renibus Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Renibus Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2019 |
| Damitta University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Kafrelsheikh University | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1